Phenotypic and Etiological Characterization of Susac Syndrome
NCT06881368 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 180
Last updated 2026-05-07
Summary
SUSAC's Syndrome (SS) is characterized by the clinical triad of encephalopathy, hearing loss, and retinal artery branch occlusions. Since the first description of SS in 1979, hundreds of patients with SS, mostly young women, have been reported. However, comprehensive epidemiological, clinical and etiological features of SS have never been specifically addressed so far.
Conditions
- Susac Syndrome
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Karim Sacre, MD, PHD · Assistance Publique - Hôpitaux de Paris
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-01
- Primary Completion
- 2044-11-30
- Completion
- 2045-02-15
Countries
- France
Study Locations
More Related Trials
-
Metabolic Study of Cockayne Syndrome
NCT03044210 ·Status: TERMINATED ·Phase: NA
-
Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young Stroke Patients
NCT00414583 ·Status: COMPLETED
-
An Observational Study in Children and Adults With Stargardt Disease
NCT06591806 ·Status: RECRUITING
-
Effects of Enzyme Replacement in Gaucher's Disease
NCT00001289 ·Status: COMPLETED
-
Natural History Study of Participants With Sanfilippo Syndrome Type IIIC
NCT05825131 ·Status: RECRUITING
-
A Natural History of Late Onset Tay-Sachs Disease
NCT02851862 ·Status: COMPLETED
-
The International Registry for Leigh Syndrome
NCT03137355 ·Status: RECRUITING
-
Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME)
NCT07287202 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Fat Distribution and Glucose Metabolism in Williams Syndrome
NCT01864304 ·Status: COMPLETED
-
Sialic Acid Supplementation in N-Acetylneuraminic Acid Synthase (NANS) Deficiency
NCT03545568 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Safety, Tolerability, and Efficacy of Long-term SOBI003 Treatment in Pediatric MPS IIIA Patients
NCT03811028 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Sirolimus for Leigh Syndrome
NCT06843811 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Randomized Controlled Study of Donepezil in Fragile X Syndrome
NCT01120626 ·Status: COMPLETED ·Phase: PHASE2
-
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
NCT05104983 ·Status: RECRUITING ·Phase: PHASE2
-
Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome
NCT03047980 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Cohort of Patients With Cystinosis : Compliance to Cysteamine and Neurological Complications
NCT02012114 ·Status: COMPLETED ·Phase: NA
-
A Retrospective Chart Review of Deceased Patients With Mucopolysaccharidosis Type IIIB
NCT02293382 ·Status: COMPLETED
-
Study of Smith-Lemli-Opitz Syndrome
NCT00001721 ·Status: COMPLETED
-
The Primordial Dwarfisms: Diagnosis, Identification of the Molecular Basis of Seckel Syndrome and Microcephalic Osteodysplastic Primordial Dwarfism Type II
NCT03139903 ·Status: COMPLETED
-
Investigating Lysosomal Storage Diseases in Minority Groups
NCT02120235 ·Status: UNKNOWN
-
Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM
NCT00490789 ·Status: UNKNOWN ·Phase: PHASE2
-
Evolution of Visual Impairment During Pseudoxanthoma Elasticum
NCT00555113 ·Status: COMPLETED
-
Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVAS
NCT07156214 ·Status: RECRUITING ·Phase: NA
-
Establishment of Biomarkers for Fabry Disease
NCT01165697 ·Status: COMPLETED
-
Biological Significance of the Bloom's Syndrome Protein
NCT00021437 ·Status: COMPLETED